Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max C Liebau

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Kidney International Reports|November 24, 2025
<i>PAX2</i>-Associated Kidney Dysplasia and Podocyte Injury: 2 Faces of a Monogenic DisorderStefan Kohl, Max C Liebau
Frontiers in Pediatrics|January 9, 2019
Editorial: Genetic Kidney Diseases of ChildhoodMiriam Schmidts, Max C Liebau
Kidney360|March 30, 2023
Fetal and Perinatal Nephrology: Small but MightyStefan Kohl, Max C Liebau
Clinical Kidney Journal|February 20, 2026
Improving precision diagnosis in unexplained CKDMax C Liebau, Detlef Böckenhauer, Peter Boor
International Journal of Molecular Sciences|August 28, 2020
Metabolic Changes in Polycystic Kidney Disease as a Potential Target for Systemic TreatmentSophie Haumann, Roman-Ulrich Müller, Max C Liebau
Advances in Kidney Disease and Health|December 14, 2023
Autosomal Recessive Polycystic Kidney Disease: Diagnosis, Prognosis, and ManagementKathrin Burgmaier, Ilse J Broekaert, Max C Liebau
Clinical Journal of the American Society of Nephrology : CJASN|August 23, 2022
Perspectives on Drug Development in Autosomal Recessive Polycystic Kidney DiseaseMax C Liebau, Erum A Hartung, Ronald D Perrone
Molecular and Cellular Pediatrics|February 24, 2021
Molecular causes of congenital anomalies of the kidney and urinary tract (CAKUT)Stefan Kohl, Sandra Habbig, Lutz T Weber, et al.
Molecular and Cellular Pediatrics|February 13, 2021
Targeted deletion of Ruvbl1 results in severe defects of epidermal development and perinatal mortalityClaudia Dafinger, Thomas Benzing, Jörg Dötsch, et al.
Kidney Medicine|January 26, 2023
Polycystic Kidney Disease Drug Development: A Conference ReportMax C Liebau, Djalila Mekahli, Ronald Perrone, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Kidney International Reports|November 24, 2025
<i>PAX2</i>-Associated Kidney Dysplasia and Podocyte Injury: 2 Faces of a Monogenic DisorderStefan Kohl, Max C Liebau
Frontiers in Pediatrics|January 9, 2019
Editorial: Genetic Kidney Diseases of ChildhoodMiriam Schmidts, Max C Liebau
Kidney360|March 30, 2023
Fetal and Perinatal Nephrology: Small but MightyStefan Kohl, Max C Liebau
Clinical Kidney Journal|February 20, 2026
Improving precision diagnosis in unexplained CKDMax C Liebau, Detlef Böckenhauer, Peter Boor
International Journal of Molecular Sciences|August 28, 2020
Metabolic Changes in Polycystic Kidney Disease as a Potential Target for Systemic TreatmentSophie Haumann, Roman-Ulrich Müller, Max C Liebau
Advances in Kidney Disease and Health|December 14, 2023
Autosomal Recessive Polycystic Kidney Disease: Diagnosis, Prognosis, and ManagementKathrin Burgmaier, Ilse J Broekaert, Max C Liebau
Clinical Journal of the American Society of Nephrology : CJASN|August 23, 2022
Perspectives on Drug Development in Autosomal Recessive Polycystic Kidney DiseaseMax C Liebau, Erum A Hartung, Ronald D Perrone
Molecular and Cellular Pediatrics|February 24, 2021
Molecular causes of congenital anomalies of the kidney and urinary tract (CAKUT)Stefan Kohl, Sandra Habbig, Lutz T Weber, et al.
Molecular and Cellular Pediatrics|February 13, 2021
Targeted deletion of Ruvbl1 results in severe defects of epidermal development and perinatal mortalityClaudia Dafinger, Thomas Benzing, Jörg Dötsch, et al.
Kidney Medicine|January 26, 2023
Polycystic Kidney Disease Drug Development: A Conference ReportMax C Liebau, Djalila Mekahli, Ronald Perrone, et al.
Pageof 7